Single-Cell Sequencing May Identify New Exercise Biomarkers
Research suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine.
Research suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine.
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.
The update integrates artificial intelligence into the system architecture to assist with case review, biomarker discovery, and laboratory operations.
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
Bio-Rad has expanded its TrailBlazer StarBright Dye Label Kits to 32 options, now available in Europe for flow cytometry and fluorescent western blot applications, according to the company.
The XR-Series features higher throughput and enhanced analytics to streamline daily laboratory operations.
The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
The new capability helps clinicians determine if a patient's infection will respond to gepotidacin before prescribing the treatment.
A study reports that long-read genome sequencing can replace up to 15 separate tests and improve diagnostic yield for rare genetic disorders, according to researchers in the Netherlands.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.